Literature DB >> 16953997

Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelines.

Berendina M Roede1, Patrick Je Bindels, Henk J Brouwer, Paul Bresser, Corianne Ajm de Borgie, Jan M Prins.   

Abstract

BACKGROUND: The Dutch College of General Practitioners' guidelines specify that antibiotics should only be used for severe cases of chronic obstructive pulmonary disease (COPD). However, GPs tend to administer antibiotics rather than a short course of steroid treatment regardless of severity. AIM: The aim of this study was to determine how GPs use current guidelines in treating exacerbations of COPD, in particular whether short courses of oral steroids and antibiotics are prescribed in accordance with the Dutch guidelines for COPD. DESIGN OF STUDY: Retrospective analysis of medical records.
SETTING: Primary healthcare centres.
METHOD: Medical records of patients registered at four primary healthcare centres in the Netherlands were retrospectively analysed for the period March 2001-March 2003.
RESULTS: Of 35,589 patients, 1.3% were registered as having a diagnosis of COPD. In 2 years, 47% of the patients had no exacerbation, 35% had one or two exacerbations, and 18% had three or more exacerbations. Of 536 exacerbations, GPs prescribed a short course of oral steroids in 30% of cases, antibiotics in 29%, steroids combined with an antibiotic in 23%, and no oral steroid course or antibiotic was prescribed in 18%. Prescriptions for patients with three or more exacerbations differed significantly from those for patients with one or two exacerbations.
CONCLUSIONS: Treatment is often not in accordance with current guidelines; in particular, antibiotics are prescribed more often than recommended.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16953997      PMCID: PMC1876631     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  16 in total

1.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.

Authors:  L Davies; R M Angus; P M Calverley
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

2.  Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: a re-evaluation of previously published data of a placebo-controlled randomized study.

Authors:  L Allegra; F Blasi; B de Bernardi; R Cosentini; P Tarsia
Journal:  Pulm Pharmacol Ther       Date:  2001       Impact factor: 3.410

3.  Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis. A double-blind, placebo-controlled multicentre study in general practice.

Authors:  A F Jørgensen; J Coolidge; P A Pedersen; K P Petersen; S Waldorff; E Widding
Journal:  Scand J Prim Health Care       Date:  1992-03       Impact factor: 2.581

4.  The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.

Authors:  D Felmingham; R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

Review 5.  Do bacteria cause exacerbations of COPD?

Authors:  J V Hirschmann
Journal:  Chest       Date:  2000-07       Impact factor: 9.410

6.  Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

Authors:  D K Chen; A McGeer; J C de Azavedo; D E Low
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

7.  A European study on the relationship between antimicrobial use and antimicrobial resistance.

Authors:  Stef L A M Bronzwaer; Otto Cars; Udo Buchholz; Sigvard Mölstad; Wim Goettsch; Irene K Veldhuijzen; Jacob L Kool; Marc J W Sprenger; John E Degener
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

8.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; J Manfreda; C P Warren; E S Hershfield; G K Harding; N A Nelson
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

9.  Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease.

Authors:  Shawn D Aaron; Katherine L Vandemheen; Paul Hebert; Robert Dales; Ian G Stiell; Jan Ahuja; Garth Dickinson; Robert Brison; Brian H Rowe; Jonathan Dreyer; Elizabeth Yetisir; Daniel Cass; George Wells
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

10.  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.

Authors: 
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

View more
  12 in total

1.  Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status.

Authors:  Javier de Miguel-Díez; Pilar Carrasco-Garrido; Javier Rejas-Gutierrez; Antonio Martín-Centeno; Elena Gobartt-Vázquez; Valentín Hernandez-Barrera; Miguel Angel Gil de; Rodrigo Jimenez-Garcia
Journal:  Lung       Date:  2011-04-17       Impact factor: 2.584

2.  Real-World Effects of Antibiotic Treatment on Acute COPD Exacerbations in Outpatients: A Cohort Study under the PharmLines Initiative.

Authors:  Yuanyuan Wang; Victor Pera; H Marike Boezen; Jan-Willem C Alffenaar; Bob Wilffert; Rolf H H Groenwold; Eelko Hak
Journal:  Respiration       Date:  2022-01-03       Impact factor: 3.966

3.  History of pneumonia is a strong risk factor for chronic obstructive pulmonary disease (COPD) exacerbation in South Korea: the Epidemiologic review and Prospective Observation of COPD and Health in Korea (EPOCH) study.

Authors:  Yong Il Hwang; Sang Haak Lee; Jee Hong Yoo; Bock Hyun Jung; Kwang Ha Yoo; Moon Jun Na; Jong Deog Lee; Myung Jae Park; Chi Young Jung; Jae Jeong Shim; Kyung Chan Kim; Yeon Jae Kim; Hye Sook Choi; Ik Su Choi; Choon-Taek Lee; Sang Do Lee; Do Jin Kim; Soo-Taek Uh; Ho Sung Lee; Young Sam Kim; Kwan Ho Lee; Seung Won Ra; Hak Ryul Kim; Soo Jeon Choi; In Won Park; Yong Bum Park; So Young Park; Jaehee Lee; Ki-Suck Jung
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

4.  EMPADE Study: Evaluation of Medical Prescriptions and Adverse Drug Events in COPD Patients Admitted to Intensive Care Unit.

Authors:  Mir S Adil; M Amer Khan; M Nematullah Khan; Ihtisham Sultan; M Aamer Khan; S Amir Ali; Afroze Farooqui
Journal:  J Clin Diagn Res       Date:  2015-11-01

5.  Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions.

Authors:  Mattias Neyt; Stephan Devriese; Nancy Thiry; Ann Van den Bruel
Journal:  BMC Pulm Med       Date:  2010-09-15       Impact factor: 3.317

6.  Predictors of treatment with antibiotics and systemic corticosteroids for acute exacerbations of asthma and chronic obstructive pulmonary disease in primary care.

Authors:  Al-ani Salwan; Mark Spigt; Johanna Laue; Hasse Melbye
Journal:  BMC Fam Pract       Date:  2015-03-24       Impact factor: 2.497

7.  How do general practitioners implement decision-making regarding COPD patients with exacerbations? An international focus group study.

Authors:  Johanna Laue; Hasse Melbye; Peder A Halvorsen; Elena A Andreeva; Maciek Godycki-Cwirko; Anja Wollny; Nick A Francis; Mark Spigt; Kenny Kung; Mette Bech Risør
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-08

8.  Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study.

Authors:  Yuanyuan Wang; Jens H Bos; H Marike Boezen; Jan-Willem C Alffenaar; J F M van Boven; Catharina C M Schuiling-Veninga; Bob Wilffert; Eelko Hak
Journal:  BMJ Open Respir Res       Date:  2020-02

Review 9.  Lung microbiology and exacerbations in COPD.

Authors:  Victoria Beasley; Priya V Joshi; Aran Singanayagam; Philip L Molyneaux; Sebastian L Johnston; Patrick Mallia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-08-31

10.  Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit.

Authors:  Rupert C M Jones; Maria Dickson-Spillmann; Martin J C Mather; Dawn Marks; Bryanie S Shackell
Journal:  Respir Res       Date:  2008-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.